Ipamorelin vs Octreotide
Overview
Ipamorelin is primarily a performance & growth peptide, while Octreotide is used for hormonal.
This page compares Ipamorelin and Octreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Ipamorelin | Octreotide | |
|---|---|---|
| Category | Performance & Growth | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 200-300 mcg | 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) |
| Frequency | twice-daily | Every 4 weeks (LAR); two to four times daily (immediate-release) |
| Reported benefits | Natural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase | Reduction of growth hormone and IGF-1 in acromegaly, suppression of carcinoid flushing and diarrhea, control of VIPoma-associated watery diarrhea, antiproliferative effect on low-grade neuroendocrine tumors, reduction of urinary 5-HIAA biomarkers |
| Reported side effects | Very well-tolerated. Rare: headache, injection site reactions | Gallstones and biliary sludge, diarrhea, nausea, abdominal discomfort, sinus bradycardia, hyperglycemia, hypoglycemia, hypothyroidism, steatorrhea, injection-site pain |
Key differences
Primary use. Ipamorelin is categorised under Performance & Growth, while Octreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Ipamorelin: not FDA-approved; treated as a research compound. Octreotide: FDA-approved.
Dosing. Ipamorelin is typically dosed at 200-300 mcg (twice-daily). Octreotide is typically dosed at 20–30 mg (LAR formulation, IM every 4 weeks); 100–600 mcg/day in divided doses (immediate-release SC) (Every 4 weeks (LAR); two to four times daily (immediate-release)).
Can you stack them?
Some protocols combine peptides, but stacking Ipamorelin and Octreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Ipamorelin and Octreotide?
- Ipamorelin is primarily a performance & growth peptide, while Octreotide is used for hormonal. Ipamorelin is not FDA-approved; generally classified as a research compound, whereas Octreotide is FDA-approved for one or more indications.
- What is Ipamorelin used for?
- GH secretagogue, anti-aging.
- What is Octreotide used for?
- FDA-approved somatostatin analog for acromegaly, carcinoid syndrome, and VIPomas since 1988.
- Can you take Ipamorelin and Octreotide together?
- Some users combine peptides within a single protocol, but stacking Ipamorelin and Octreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Ipamorelin or Octreotide FDA-approved?
- Ipamorelin is not FDA-approved; generally classified as a research compound. Octreotide is FDA-approved for one or more indications.
Read the full articles
- Ipamorelin — full monograph: mechanism, research, dosing & references
- Octreotide — full monograph: mechanism, research, dosing & references